SLC6 Transporter Folding Diseases and Pharmacochaperoning
The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
The human genome encodes 19 genes of the solute carrier 6 (SLC6) family; non-synonymous changes in the coding sequence give rise to mutated transporters, which are misfolded and thus cause diseases in the affected individuals. Prominent examples include mutations in the transporters for dopamine (DAT, SLC6A3), for creatine (CT1, SLC6A8), and for glycine (GlyT2, SLC6A5), which result in infantile dystonia, mental retardation, and hyperekplexia, respectively. Thus, there is an obvious unmet medical need to identify compounds, which can remedy the folding deficit. The pharmacological correction of folding defects was originally explored in mutants of the serotonin transporter (SERT, SLC6A4), which were created to study the COPII-dependent export from the endoplasmic reticulum. This led to the serendipitous discovery of the pharmacochaperoning action of ibogaine. Ibogaine and its metabolite noribogaine also rescue several disease-relevant mutants of DAT. Because the pharmacology of DAT and SERT is exceptionally rich, it is not surprising that additional compounds have been identified, which rescue folding-deficient mutants. These compounds are not only of interest for restoring DAT function in the affected children. They are also likely to serve as useful tools to interrogate the folding trajectory of the transporter. This is likely to initiate a virtuous cycle: if the principles underlying folding of SLC6 transporters are understood, the design of pharmacochaperones ought to be facilitated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Low brain creatine content has been associated with muscle myopathies (e.g., weakness), voluntary or involuntary movement disorders that can affect muscle function and coordination, speech development, epilepsy, cognitive and motor development delays, and/or autism [53,61,203,204,206,207,208,209,210].”
From Creatine in health and disease (2021) · cites this paper as [204]
In the citing paper
“For this reason, high-dose, long-term creatine supplementation (e.g., 0.3–0.8 g/kg/day) throughout the lifespan is a nutritional strategy of increasing brain creatine content in these populations [53,61,203,204,206,207,208,209,210,211,212,213,214].”
From Creatine in health and disease (2021) · cites this paper as [204]
Citations
Cites
Principles that Govern the Folding of Protein Chains
Anfinsen, C. B. (1973) · Science · doi:10.1126/science.181.4096.223 · Cited by 7,096
Journal of Biological Chemistry
(2021) · Journal of Biological Chemistry · doi:10.1074/jbc · Cited by 3,400
Statistical potential for assessment and prediction of protein structures
Shen, M., & Sali, A. (2006) · Protein Science · doi:10.1110/ps.062416606 · Cited by 2,307
The Protein-Folding Problem, 50 Years On
Dill, K. A., & MacCallum, J. L. (2012) · Science · doi:10.1126/science.1219021 · Cited by 1,699
Löscher, W. (2011) · Seizure · doi:10.1016/j.seizure.2011.01.003 · Cited by 932
X-ray structures and mechanism of the human serotonin transporter
Coleman, J. A., Green, E. M., & Gouaux, E. (2016) · Nature · doi:10.1038/nature17629 · Cited by 668
X-ray structure of dopamine transporter elucidates antidepressant mechanism
Penmatsa, A., Wang, K. H., & Gouaux, E. (2013) · Nature · doi:10.1038/nature12533 · Cited by 612
Dopamine Is a Regulator of Arousal in the Fruit Fly
Kume, K., Kume, S., Park, S. K., Hirsh, J., & Jackson, F. R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2048-05.2005 · Cited by 597
Orthostatic Intolerance and Tachycardia Associated with Norepinephrine-Transporter Deficiency
Shannon, J. R., Flattem, N. L., Jordan, J., Jacob, G., Black, B. K., Biaggioni, I., Blakely, R. D., & Robertson, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002243420803 · Cited by 594
Enhanced tonic GABAA inhibition in typical absence epilepsy
Cope, D. W., Di Giovanni, G., Fyson, S. J., Orbán, G., Errington, A. C., Lőrincz, M. L., Gould, T. M., Carter, D. A., & Crunelli, V. (2009) · Nature Medicine · doi:10.1038/nm.2058 · Cited by 431
COPII and the regulation of protein sorting in mammals
Zanetti, G., Pahuja, K. B., Studer, S., Shim, S., & Schekman, R. (2012) · Nature Cell Biology · doi:10.1038/ncb2390 · Cited by 378
Mechanisms of Integral Membrane Protein Insertion and Folding
Cymer, F., von Heijne, G., & White, S. H. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.09.014 · Cited by 360
Swistowski, A., Peng, J., Liu, Q., Mali, P., Rao, M. S., Cheng, L., & Zeng, X. (2010) · Stem Cells · doi:10.1002/stem.499 · Cited by 317
Camargo, S. M. R., Singer, D., Makrides, V., Huggel, K., Pos, K. M., Wagner, C. A., Kuba, K., Danilczyk, U., Skovby, F., Kleta, R., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.055 · Cited by 282
Amphetamines, new psychoactive drugs and the monoamine transporter cycle
Sitte, H. H., & Freissmuth, M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.11.006 · Cited by 276
Self-citationThe solute carrier 6 family of transporters
Bröer, S., & Gether, U. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01975.x · Cited by 269
Rubenstein, R. C., & Zeitlin, P. L. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.278.2.c259 · Cited by 269
Chiu, C.-S., Brickley, S., Jensen, K., Southwell, A., Mckinney, S., Cull-Candy, S., Mody, I., & Lester, H. A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3364-04.2005 · Cited by 238
Rees, M. I., Harvey, K., Pearce, B. R., Chung, S.-K., Duguid, I. C., Thomas, P., Beatty, S., Graham, G. E., Armstrong, L., Shiang, R., et al. (2006) · Nature Genetics · doi:10.1038/ng1814 · Cited by 236
Mutations in the GABA Transporter SLC6A1 Cause Epilepsy with Myoclonic-Atonic Seizures
Carvill, G. L., McMahon, J. M., Schneider, A., Zemel, M., Myers, C. T., Saykally, J., Nguyen, J., Robbiano, A., Zara, F., Specchio, N., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.02.016 · Cited by 227
A protein complex in the brush‐border membrane explains a Hartnup disorder allele
Kowalczuk, S., Bröer, A., Tietze, N., Vanslambrouck, J. M., Rasko, J. E. J., & Bröer, S. (2008) · The FASEB Journal · doi:10.1096/fj.08-107300 · Cited by 220
Schmid, J. A., Scholze, P., Kudlacek, O., Freissmuth, M., Singer, E. A., & Sitte, H. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007357200 · Cited by 216
Self-citationKurian, M. A., Li, Y., Zhen, J., Meyer, E., Hai, N., Christen, H.-J., Hoffmann, G. F., Jardine, P., von Moers, A., Mordekar, S. R., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70269-6 · Cited by 203
Phenotype and genotype in 101 males with X-linked creatine transporter deficiency
van de Kamp, J. M., Betsalel, O. T., Mercimek-Mahmutoglu, S., Abulhoul, L., Grünewald, S., Anselm, I., Azzouz, H., Bratkovic, D., de Brouwer, A., Hamel, B., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101658 · Cited by 164
Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood
Ng, J., Zhen, J., Meyer, E., Erreger, K., Li, Y., Kakar, N., Ahmad, J., Thiele, H., Kubisch, C., Rider, N. L., et al. (2014) · Brain · doi:10.1093/brain/awu022 · Cited by 157
Missense dopamine transporter mutations associate with adult parkinsonism and ADHD
Hansen, F. H., Skjørringe, T., Yasmeen, S., Arends, N. V., Sahai, M. A., Erreger, K., Andreassen, T. F., Holy, M., Hamilton, P. J., Neergheen, V., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73778 · Cited by 145
Jacobs, M. T., Zhang, Y.-W., Campbell, S. D., & Rudnick, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704456200 · Cited by 136
The N Terminus of Monoamine Transporters Is a Lever Required for the Action of Amphetamines
Sucic, S., Dallinger, S., Zdrazil, B., Weissensteiner, R., Jørgensen, T. N., Holy, M., Kudlacek, O., Seidel, S., Cha, J. H., Gether, U., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.083154 · Cited by 136
Self-citationX‐linked creatine transporter deficiency: clinical aspects and pathophysiology
van de Kamp, J. M., Mancini, G. M., & Salomons, G. S. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9713-8 · Cited by 118
The Mechanistic Basis for Noncompetitive Ibogaine Inhibition of Serotonin and Dopamine Transporters
Bulling, S., Schicker, K., Zhang, Y.-W., Steinkellner, T., Stockner, T., Gruber, C. W., Boehm, S., Freissmuth, M., Rudnick, G., Sitte, H. H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.343681 · Cited by 115
Self-citationBröer, S., Bailey, C. G., Kowalczuk, S., Ng, C., Vanslambrouck, J. M., Rodgers, H., Auray-Blais, C., Cavanaugh, J. A., Bröer, A., & Rasko, J. E. J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36625 · Cited by 115
Scholze, P., Freissmuth, M., & Sitte, H. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205602200 · Cited by 112
Self-citationJust, H., Sitte, H. H., Schmid, J. A., Freissmuth, M., & Kudlacek, O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306092200 · Cited by 108
Self-citationBröer, S. (2009) · IUBMB Life · doi:10.1002/iub.210 · Cited by 107
Hahn, M. K., Robertson, D., & Blakely, R. D. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-11-04470.2003 · Cited by 107
Farhan, H., Reiterer, V., Korkhov, V. M., Schmid, J. A., Freissmuth, M., & Sitte, H. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609720200 · Cited by 100
Self-citationDirect PIP2 binding mediates stable oligomer formation of the serotonin transporter
Anderluh, A., Hofmaier, T., Klotzsch, E., Kudlacek, O., Stockner, T., Sitte, H. H., & Schütz, G. J. (2017) · Nature Communications · doi:10.1038/ncomms14089 · Cited by 97
Self-citationSucic, S., El-Kasaby, A., Kudlacek, O., Sarker, S., Sitte, H. H., Marin, P., & Freissmuth, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.230037 · Cited by 84
Self-citationMutations in the GlyT2 Gene (SLC6A5) Are a Second Major Cause of Startle Disease
Carta, E., Chung, S.-K., James, V. M., Robinson, A., Gill, J. L., Remy, N., Vanbellinghen, J.-F., Drew, C. J. G., Cagdas, S., Cameron, D., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.372094 · Cited by 84
ER retention is imposed by COPII protein sorting and attenuated by 4-phenylbutyrate
Ma, W., Goldberg, E., & Goldberg, J. D. (2017) · eLife · doi:10.7554/elife.26624 · Cited by 81
Farhan, H., Korkhov, V. M., Paulitschke, V., Dorostkar, M. M., Scholze, P., Kudlacek, O., Freissmuth, M., & Sitte, H. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307325200 · Cited by 77
Self-citationStockner, T., Montgomery, T., Kudlacek, O., Weissensteiner, R., Ecker, G. F., Freissmuth, M., & Sitte, H. H. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002909 · Cited by 76
Self-citationTreatment Options in Juvenile Myoclonic Epilepsy
Ritter, L. M., & Walker, M. C. (2011) · Current Treatment Options in Neurology · doi:10.1007/s11940-011-0131-z · Cited by 76
El‐Kasaby, A., Just, H., Malle, E. K., Stolt-Bergner, P. C., Sitte, H. H., Freissmuth, M., & Kudlacek, O. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.118000 · Cited by 74
Self-citationMutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia
Eulenburg, V., Becker, K., Gomeza, J., Schmitt, B., Becker, C., & Betz, H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.080 · Cited by 69
Orphan Transporter SLC6A18 Is Renal Neutral Amino Acid Transporter B0AT3
Singer, D., Camargo, S. M. R., Huggel, K., Romeo, E., Danilczyk, U. G., Kuba, K., Chesnov, S., Caron, M. G., Penninger, J. M., & Verrey, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.011171 · Cited by 67
Hasenhuetl, P. S., Freissmuth, M., & Sandtner, W. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.753319 · Cited by 61
Self-citationBeerepoot, P., Lam, V. M., & Salahpour, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.749119 · Cited by 58
Sučić, S., Koban, F., El‐Kasaby, A., Kudlacek, O., Stockner, T., Sitte, H. H., & Freissmuth, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.408237 · Cited by 57
Self-citationSLC6A1 Mutation and Ketogenic Diet in Epilepsy With Myoclonic-Atonic Seizures
Palmer, S., Towne, M. C., Pearl, P. L., Pelletier, R. C., Genetti, C. A., Shi, J., Beggs, A. H., Agrawal, P. B., & Brownstein, C. A. (2016) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2016.07.012 · Cited by 57
Prion Protein Helix1 Promotes Aggregation but Is Not Converted into beta-Sheet
Watzlawik, J. O., Skóra, L., Frense, D., Griesinger, C., Zweckstetter, M., Schulz‐Schaeffer, W., & Kramer, M. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605141200 · Cited by 55
Fairweather, S. J., Bröer, A., Subramanian, N., Tümer, E., Cheng, Q., Schmoll, D., O’Mara, M. L., & Bröer, S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.648519 · Cited by 54
Parra, L. A., Baust, T., El Mestikawy, S., Quiroz, M., Hoffman, B., Haflett, J. M., Yao, J. K., & Torres, G. E. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.050005 · Cited by 53
Molecular diversity of combined and complex dystonia: insights from diagnostic exome sequencing
Zech, M., Jech, R., Wagner, M., Mantel, T., Boesch, S., Nocker, M., Jochim, A., Berutti, R., Havránková, P., Fečíková, A., et al. (2017) · Neurogenetics · doi:10.1007/s10048-017-0521-9 · Cited by 53
Asjad, H. M. M., Kasture, A., El-Kasaby, A., Sackel, M., Hummel, T., Freissmuth, M., & Sucic, S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.797092 · Cited by 53
Self-citationEl-Kasaby, A., Koban, F., Sitte, H. H., Freissmuth, M., & Sucic, S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.595090 · Cited by 51
Self-citationSynaptic Vesicle Protein NTT4/XT1 (SLC6A17) Catalyzes Na+-coupled Neutral Amino Acid Transport
Zaia, K. A., & Reimer, R. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806407200 · Cited by 51
Korkhov, V. M., Holy, M., Freissmuth, M., & Sitte, H. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511382200 · Cited by 49
Self-citationKurian, M. A., Zhen, J., Cheng, S.-Y., Li, Y., Mordekar, S. R., Jardine, P., Morgan, N. V., Meyer, E., Tee, L., Pasha, S., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39060 · Cited by 49
Farhan, H., Freissmuth, M., & Sitte, H. H. (2006) · Handbook of experimental pharmacology · doi:10.1007/3-540-29784-7_12 · Cited by 47
Self-citationDefining the blanks – Pharmacochaperoning of SLC6 transporters and ABC transporters
Chiba, P., Freissmuth, M., & Stockner, T. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.009 · Cited by 47
Self-citationKasture, A. S., El‐Kasaby, A., Szöllősi, D., Asjad, H. M. M., Grimm, A., Stockner, T., Hummel, T., Freissmuth, M., & Sučić, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.737551 · Cited by 47
Self-citationKoban, F., El‐Kasaby, A., Häusler, C., Stockner, T., Simbrunner, B., Sitte, H. H., Freissmuth, M., & Sučić, S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.641357 · Cited by 45
Self-citationKurolap, A., Armbruster, A., Hershkovitz, T., Hauf, K., Mory, A., Paperna, T., Hannappel, E., Tal, G., Nijem, Y., Sela, E., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.09.004 · Cited by 43
Dikow, N., Maas, B., Karch, S., Granzow, M., Janssen, J. W. G., Jauch, A., Hinderhofer, K., Sutter, C., Schubert‐Bast, S., Anderlid, B. M., et al. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36761 · Cited by 42
Alfadhel, M., Nashabat, M., Qahtani, H. A., Alfares, A. A., Mutairi, F. A., Alshaalan, H., Douglas, G. V., Wierenga, K. J., Juusola, J., Alrifai, M. T., et al. (2016) · Human Genetics · doi:10.1007/s00439-016-1719-x · Cited by 42
Novel Mutation in SLC6A19 Causing Late-Onset Seizures in Hartnup Disorder
Cheon, C. K., Lee, B. H., Ko, J. M., Kim, H.-J., & Yoo, H. (2010) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2010.01.009 · Cited by 41
DesRoches, C.-L., Patel, J., Wang, P., Minassian, B. A., Salomons, G. S., Marshall, C. R., & Mercimek‐Andrews, S. (2015) · Gene · doi:10.1016/j.gene.2015.04.011 · Cited by 41
Korkhov, V. M., Farhan, H., Freissmuth, M., & Sitte, H. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409449200 · Cited by 40
Self-citationBhat, S., Hasenhuetl, P. S., Kasture, A. S., El‐Kasaby, A., Baumann, M. H., Blough, B. E., Sučić, S., Sandtner, W., & Freissmuth, M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.794081 · Cited by 39
Self-citationThe C-Terminus Is Critical for the Functional Expression of the Human Serotonin Transporter
Larsen, M. B., Fjorback, A. W., & Wiborg, O. (2006) · Biochemistry · doi:10.1021/bi0508688 · Cited by 38
Giménez, C., Pérez‐Siles, G., Martínez-Villarreal, J., Arribas-González, E., Jiménez, E., Núñez, E., de Juan‐Sanz, J., Fernández-Sánchez, E., García‐Tardón, N., Ibáñez, I., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.319244 · Cited by 38
Dual Action of Zn2+ on the Transport Cycle of the Dopamine Transporter
Li, Y., Hasenhuetl, P. S., Schicker, K. W., Sitte, H. H., Freissmuth, M., & Sandtner, W. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.688275 · Cited by 38
Self-citationArribas-González, E., de Juan‐Sanz, J., Aragón, C., & López‐Corcuera, B. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.587055 · Cited by 35
Rosenberg, A., & Kanner, B. I. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801093200 · Cited by 33
Korkhov, V. M., Milan‐Lobo, L., Zuber, B., Farhan, H., Schmid, J. A., Freissmuth, M., & Sitte, H. H. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.02.056 · Cited by 32
Self-citationLi, Y., Mayer, F. P., Hasenhuetl, P. S., Burtscher, V., Schicker, K. W., Sitte, H. H., Freissmuth, M., & Sandtner, W. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.760140 · Cited by 29
Self-citationTracking Single Serotonin Transporter Molecules at the Endoplasmic Reticulum and Plasma Membrane
Anderluh, A., Klotzsch, E., Ries, J., Reismann, A. W. A. F., Weber, S., Fölser, M., Koban, F., Freissmuth, M., Sitte, H. H., & Schütz, G. J. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.03.019 · Cited by 28
Self-citationFujiwara, M., Yamamoto, H., Miyagi, T., Seki, T., Tanaka, S., Hide, I., & Sakai, N. (2013) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12194fp · Cited by 26
Ben-Yona, A., & Kanner, B. I. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.430215 · Cited by 26
Creatine transporter deficiency: Novel mutations and functional studies
Ardon, O., Procter, M., Mao, R., Longo, N., Landau, Y. E., Shilon-Hadass, A., Gabis, L. V., Hoffmann, C., Tzadok, M., Heimer, G., et al. (2016) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2016.06.005 · Cited by 25
The N Terminus Specifies the Switch between Transport Modes of the Human Serotonin Transporter
Kern, C. C., Erdem, F. A., El‐Kasaby, A., Sandtner, W., Freissmuth, M., & Sučić, S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.771360 · Cited by 21
Self-citationSučić, S., & Bryan‐Lluka, L. J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03316.x · Cited by 19
Janowsky, A. J., Tosh, D. K., Eshleman, A. J., & Jacobson, K. A. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.229666 · Cited by 19
A novel missense mutation in the SLC6A19 gene in a Chinese family with Hartnup disorder
Zheng, Y., Zhou, C., Huang, Y., Bu, D., Zhu, X., & Jiang, W. (2009) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2009.03989.x · Cited by 18
Kusek, J., Yang, Q., Witek, M., Gruber, C. W., Nanoff, C., & Freissmuth, M. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.094045 · Cited by 18
Self-citationHyperekplexia: Report on phenotype and genotype of 16 Jordanian patients
Masri, A. T., Chung, S., & Rees, M. I. (2016) · Brain and Development · doi:10.1016/j.braindev.2016.10.010 · Cited by 17
Uemura, T., Ito, S., Ohta, Y., Tachikawa, M., Wada, T., Terasaki, T., & Ohtsuki, S. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00582 · Cited by 17
An unfolding story: Small molecules remedy misfolded monoamine transporters
Kasture, A. S., Stockner, T., Freissmuth, M., & Sučić, S. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.09.004 · Cited by 16
Self-citationSeyer, P., Vandermoere, F., Cassier, E., Bockaert, J., & Marin, P. (2016) · Biochemical Journal · doi:10.1042/bcj20160315 · Cited by 11
Sučić, S., & Bryan‐Lluka, L. J. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.10.058 · Cited by 6
Research works printed but not linked: 1
- Levinthal C (1969) How to fold graciously. In: DeBrunner JTP, Munck E (eds) Mössbauer spectroscopy in biological systems. University of Illinois Press, Allerton House, Monticello, IL, pp 22–24
Cited by
Creatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
Kasture, A. S., Hummel, T., Sučić, S., & Freissmuth, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061788 · Cited by 108
Self-citationA systematic literature review of clinical trials and therapeutic applications of ibogaine
Köck, P., Froelich, K., Walter, M., Lang, U. E., & Dürsteler, K. M. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108717 · Cited by 88
The Creatine Transporter Unfolded: A Knotty Premise in the Cerebral Creatine Deficiency Syndrome
Farr, C. V., El‐Kasaby, A., Freissmuth, M., & Sučić, S. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.588954 · Cited by 58
Self-citationEl‐Kasaby, A., Kasture, A. S., Koban, F., Hoťka, M., Asjad, H. M. M., Kubista, H., Freissmuth, M., & Sučić, S. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.03.015 · Cited by 58
Self-citation
Metadata
- Authors
- Freissmuth, M., Stockner, T., & Sucic, S.
- Affiliations
- Medical University of Vienna (AT)
- Corresponding author
- Freissmuth, Michael
- Venue
- Handbook of experimental pharmacology
- Publisher
- Springer International Publishing
- Published
- 2017
- Volume
- 245
- Pages
- 249-270
- ISSN
- 0171-2004 (ISSN-L)
- 1865-0325
- OpenAlex
- W2765579156
- Cited by
- 42
- References
- 90
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 7 · 2022: 4 · 2021: 7 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 1
- FWCI
- 4.08
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Handbook of experimental pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
- Keywords
- pharmacochaperone, protein folding defects, dopamine transporter, serotonin transporter, creatine transporter, glycine transporter, ibogaine, noribogaine, hyperekplexia, intellectual disability, endoplasmic reticulum
- MeSH terms
- Solute Carrier Proteins, Animals, Humans, Mutation, Protein Folding, Molecular Chaperones, Dopamine Plasma Membrane Transport Proteins, Serotonin Plasma Membrane Transport Proteins, Drug Discovery, Proteostasis Deficiencies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.